DMC Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$358K Sell
9,754
-704
-7% -$33.4K 0.24% 103
2025
Q4
$532K Sell
10,458
-731
-7% -$37.4K 0.35% 81
2025
Q3
$621K Buy
11,189
+853
+8% +$49.9K 0.43% 72
2025
Q2
$713K Sell
10,336
-819
-7% -$55.7K 0.55% 59
2025
Q1
$775K Sell
11,155
-150
-1% -$12.4K 0.63% 50
2024
Q4
$972K Sell
11,305
-1,061
-9% -$115K 0.79% 39
2024
Q3
$1.47M Sell
12,366
-186
-1% -$24.8K 1.19% 21
2024
Q2
$1.79M Sell
12,552
-850
-6% -$113K 1.54% 11
2024
Q1
$1.72M Buy
13,402
+951
+8% +$113K 1.49% 14
2023
Q4
$1.29M Sell
12,451
-2,691
-18% -$266K 1.22% 22
2023
Q3
$1.38M Buy
15,142
+728
+5% +$64.1K 1.29% 18
2023
Q2
$1.17M Sell
14,414
-1,858
-11% -$152K 1.17% 20
2023
Q1
$1.3M Sell
16,272
-530
-3% -$37.6K 1.31% 17
2022
Q4
$1.15M Sell
16,802
-46
-0.3% -$2.7K 1.3% 13
2022
Q3
$864K Sell
16,848
-338
-2% -$18.1K 1.04% 24
2022
Q2
$959K Sell
17,186
-316
-2% -$17.5K 1.14% 21
2022
Q1
$969K Sell
17,502
-10,294
-37% -$528K 1.08% 19
2021
Q4
$1.33M Buy
+27,796
New +$1.51M 1.14% 19

Other funds holding NVO

DMC Group's NVO Position: Q1 2026 in Review

DMC Group reduced its Novo Nordisk (NVO) stake by 6.7% in Q1 2026, selling an estimated $33.4K and leaving 9,754 shares worth $358K. The position accounts for 0.24% of the portfolio, ranked #103.

DMC Group first reported a position in NVO in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.79M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • DMC Group held 9,754 shares of Novo Nordisk worth $358K as of Q1 2026.
  • DMC Group sold 704 Novo Nordisk shares in Q1 2026, an estimated $33.4K.
  • Novo Nordisk made up 0.24% of DMC Group's portfolio in Q1 2026, its #103 holding.
  • DMC Group first reported a position in Novo Nordisk in Q4 2021 and has held it in 18 quarters since.
  • DMC Group's Novo Nordisk position peaked at $1.79M in Q2 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on DMC Group's 13F filing for Q1 2026, filed 30 Apr 2026.